Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Fractional Flow Reserve-Guided Percutaneous Coronary Intervention Plus Optimal Medical Treatment Versus Optimal Medical Treatment Alone in Patients With Stable Coronary Artery Disease

NCT01132495 is registered in ClinicalTrials.gov with Abbott Medical Devices as lead sponsor.

NCT NCT01132495
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01132495 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Fractional Flow Reserve-Guided Percutaneous Coronary Intervention Plus Optimal Medical Treatment Versus Optimal Medical Treatment Alone in Patients With Stable Coronary Artery Disease
Lead sponsor
Abbott Medical Devices
Phase
Not applicable
Overall status
Completed
Start date
May 31, 2010
Completion date
May 31, 2015
Enrollment
1,170 (actual)
Sites
29

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease